169 related articles for article (PubMed ID: 37153896)
1. Decreased SPTBN2 expression regulated by the ceRNA network is associated with poor prognosis and immune infiltration in low‑grade glioma.
Chen GR; Zhang YB; Zheng SF; Xu YW; Lin P; Shang-Guan HC; Lin YX; Kang DZ; Yao PS
Exp Ther Med; 2023 Jun; 25(6):253. PubMed ID: 37153896
[TBL] [Abstract][Full Text] [Related]
2. Elevated Hexose-6-Phosphate Dehydrogenase Regulated by OSMR-AS1/hsa-miR-516b-5p Axis Correlates with Poor Prognosis and Dendritic Cells Infiltration of Glioblastoma.
Zhang YB; Zheng SF; Ma LJ; Lin P; Shang-Guan HC; Lin YX; Kang DZ; Yao PS
Brain Sci; 2022 Jul; 12(8):. PubMed ID: 36009075
[TBL] [Abstract][Full Text] [Related]
3. CERS6-AS1 contributes to the malignant phenotypes of colorectal cancer cells by interacting with miR-15b-5p to regulate SPTBN2.
Zhao SY; Wang Z; Wu XB; Zhang S; Chen Q; Wang DD; Tan QF
Kaohsiung J Med Sci; 2022 May; 38(5):403-414. PubMed ID: 35146902
[TBL] [Abstract][Full Text] [Related]
4. A ceRNA network of BBOX1-AS1-hsa-miR-125b-5p/hsa-miR-125a-5p-CDKN2A shows prognostic value in cervical cancer.
Wang T; Zhang XD; Hua KQ
Taiwan J Obstet Gynecol; 2021 Mar; 60(2):253-261. PubMed ID: 33678324
[TBL] [Abstract][Full Text] [Related]
5. SLC10A3 Is a Prognostic Biomarker and Involved in Immune Infiltration and Programmed Cell Death in Lower Grade Glioma.
Ma W; Mei P
World Neurosurg; 2023 Oct; 178():e595-e640. PubMed ID: 37543196
[TBL] [Abstract][Full Text] [Related]
6. Effects of 1p/19q Codeletion on Immune Phenotype in Low Grade Glioma.
Lv L; Zhang Y; Zhao Y; Wei Q; Zhao Y; Yi Q
Front Cell Neurosci; 2021; 15():704344. PubMed ID: 34335194
[No Abstract] [Full Text] [Related]
7. A Key mRNA-miRNA-lncRNA Competing Endogenous RNA Triple Sub-network Linked to Diagnosis and Prognosis of Hepatocellular Carcinoma.
Zhang J; Lou W
Front Oncol; 2020; 10():340. PubMed ID: 32257949
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in human aortic dissection.
Zhang H; Bian C; Tu S; Yin F; Guo P; Zhang J; Song X; Liu Q; Chen C; Han Y
BMC Genomics; 2021 Oct; 22(1):724. PubMed ID: 34620091
[TBL] [Abstract][Full Text] [Related]
9. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
Zhong C; Yu Q; Peng Y; Zhou S; Liu Z; Deng Y; Guo L; Zhao S; Chen G
J Exp Clin Cancer Res; 2021 Apr; 40(1):123. PubMed ID: 33832517
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of the lncRNA-miRNA-mRNA regulatory network for bladder cancer.
Huang M; Long Y; Jin Y; Ya W; Meng D; Qin T; Su L; Zhou W; Wu J; Huang C; Huang Q
Transl Androl Urol; 2021 Mar; 10(3):1286-1301. PubMed ID: 33850763
[TBL] [Abstract][Full Text] [Related]
11. Construction and Analysis of Immune Infiltration-Related ceRNA Network for Kidney Stones.
Xia Y; Zhou X; Ye Z; Yu W; Ning J; Ruan Y; Yuan R; Lin F; Ye P; Zheng D; Rao T; Cheng F
Front Genet; 2021; 12():774155. PubMed ID: 34938320
[No Abstract] [Full Text] [Related]
12. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
[TBL] [Abstract][Full Text] [Related]
13. CCNB2 is a novel prognostic factor and a potential therapeutic target in low-grade glioma.
Wang D; Sun H; Li X; Wang G; Yan G; Ren H; Hou B
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34908101
[TBL] [Abstract][Full Text] [Related]
14. Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma.
Li X; Zhang J; Zhang M; Qi X; Wang S; Teng J
Medicine (Baltimore); 2021 Oct; 100(39):e27248. PubMed ID: 34596120
[TBL] [Abstract][Full Text] [Related]
15. Integrated analysis to reveal potential therapeutic targets and prognostic biomarkers of skin cutaneous melanoma.
Zhou X; Rong R; Xiong S; Song W; Ji D; Xia X
Front Immunol; 2022; 13():914108. PubMed ID: 36032150
[TBL] [Abstract][Full Text] [Related]
16. Construction of ceRNA networks with different types of
Wang WJ; Lu YJ; Li Y; Tang JQ; Wang H; Song W; Wang JJ; Huang YQ; Wang Y; Lian L
Ann Transl Med; 2022 Mar; 10(5):254. PubMed ID: 35402587
[TBL] [Abstract][Full Text] [Related]
17. Identification of Potential lncRNAs and miRNAs as Diagnostic Biomarkers for Papillary Thyroid Carcinoma Based on Machine Learning.
Yang F; Zhang J; Li B; Zhao Z; Liu Y; Zhao Z; Jing S; Wang G
Int J Endocrinol; 2021; 2021():3984463. PubMed ID: 34335744
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-mediated ceRNA network was identified as a crucial determinant of differential effects in periodontitis and periimplantitis by high-throughput sequencing.
Zhou H; Chen D; Xie G; Li J; Tang J; Tang L
Clin Implant Dent Relat Res; 2020 Jun; 22(3):424-450. PubMed ID: 32319195
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA hsa_circ_0005114-miR-142-3p/miR-590-5p-adenomatous polyposis coli protein axis as a potential target for treatment of glioma.
Wei B; Wang L; Zhao J
Oncol Lett; 2021 Jan; 21(1):58. PubMed ID: 33281969
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Transcriptomic Analysis and Experimental Validation Identify lncRNA HOXA-AS2/miR-184/COL6A2 as the Critical ceRNA Regulation Involved in Low-Grade Glioma Recurrence.
Chen PY; Li XD; Ma WN; Li H; Li MM; Yang XY; Li SY
Onco Targets Ther; 2020; 13():4999-5016. PubMed ID: 32581558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
